This course is designed for health professionals, industry professionals, researchers and other professionals seeking to advance or refresh skills and knowledge in high-demand areas.

This includes oncology physician specialists (medical, radiation, surgical), cancer nurses, cancer allied health professionals, clinical trial assistants, study coordinators, investigators, researchers, biomedical and pharmaceutical scientists, general practitioners.

To enrol in this course, you require a bachelors degree in a relevant area.

This course has been co-designed with the VCCC Alliance, an alliance of 10 leading research, clinical and academic institutions with a shared commitment to saving lives through the integration of cancer research, education and patient care.

The scale and depth of the Centre's expertise, knowledge, practice and patient numbers provide unprecedented access to learn from the pioneers driving the next generation of improvements in prevention, detection and cancer treatment.

Learning in this course is aligned to the following industry standards and guidelines:

• ICH Good Clinical Practice guidelines
• National Clinical Trials Governance Framework
• Therapeutic Goods Act 1989 (Cth)
• PIC/S Guide to Good Manufacturing Practice for Medicinal Products PE 009-13, Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme 2017.

This Melbourne MicroCert is designed to rapidly build your knowledge and confidence in a sought-after skill area, and provide you with the guidance to apply this within your own practice.

By the end of this course, you'll have a strong grounding in how the drug commercialisation pipeline operates. You'll be able to:

• Identify the various economic, intellectual property and strategic alliance considerations involved in embarking on commercial partnerships
• Explain the steps involved from identifying a candidate, to commercialisation of a product through a commercial drug venture pitch.

This Melbourne MicroCert runs over six weeks, including four weeks of guided learning and two weeks of asynchronous learning inclusive of assessment tasks.

Your total time commitment is approximately 42 hours, which includes:

• 12 hours guided learning, including a one-hour webinar
• 10 hours self and peer learning
• 20 hours feedback or assessment tasks

Assessment:

• Grant proposal (50%)
• Oral pitch (50%)

Once you've successfully completed this course, you will be awarded your Drug Commercialisation Fundamentals Melbourne MicroCert. This digital certificate will warrant the achievement of knowledge, skills and capabilities outlined in the learning outcomes. It may also include artefacts (such as videos and written material) related to both experiential and work-integrated learning, including translatable assessment that is practical to your professional life. You can also share your Melbourne MicroCert digitally and via social media by adding it to your personal platforms, such as LinkedIn. See example certificate.

Drug Commercialisation Fundamentals can be taken as a stand-alone course or complemented with any other Melbourne MicroCert in the Emerging Topics in Oncology series to deepen your knowledge and skills.

It also offers a pathway – otherwise known as advanced standing – into the Master of Cancer Sciences. To use it this way, you need to complete all four Melbourne MicroCerts in the Emerging Topics in Oncology series, then apply for credit towards the qualification.

The series includes:

• Clinical Trial Protocol Design
• Using Genomic Data for Personalised Care
• Drug Commercialisation Fundamentals

Throughout this fully online course, you'll undertake both guided and self-directed learning, enabling you to implement your new knowledge within your practice.

Our facilitators and content experts have been drawn from the VCCC Alliance's extensive networks, meaning you'll hear from world-leading oncological voices.

Guided learning in this course includes a one-hour webinar, interactive activities and a discussion forum. You'll also receive valuable coaching, feedback and assessment guidance from your course facilitators.

By joining the online discussion, you'll become part of an engaged network of cancer care professionals who are passionate about providing top-quality clinical care and contributing to high-impact cancer research.

This Melbourne MicroCert will expire five years after the date of issue as particular knowledge or skills may need to be refreshed.